Samir N. Khleif

8.5k citations
114 papers · 4.6k indexed · 1 hit paper · h-index 39
Topics
Immunotherapy and Immune Responses (54 papers)Cancer Immunotherapy and Biomarkers (53 papers)CAR-T cell therapy research (21 papers)
Partner nations
United StatesFranceItaly

In The Last Decade

Samir N. Khleif

112 papers receiving 4.6k citations

Hit Papers

Randomized Phase II Trial of Nivolumab Versus Nivolumab a...2020202620222024202050100150200

Peers

Samir N. Khleif
Comparison fields: 5 of 120
  • Oncology 3.0k
  • Immunology 1.9k
  • Molecular Biology 1.2k
  • Pulmonary and Respiratory Medicine 731
  • Epidemiology 484
Replace Marianna Nuti with:
Marianna Nuti Italy
Hideto Tamura Japan
Ravi A. Madan United States
Marij J.P. Welters Netherlands
Colleen Simpson United States
Yoshiko Iwai Japan
Giuseppe Masucci Sweden
Katia Schlienger United States
Christian H. Ottensmeier United Kingdom
Yuanyuan Zha United States
Samir N. Khleif relative to Marianna Nuti Italy Marianna Nuti's profile →
Citations per field
00.5×3.3×
Marianna Nuti · 1×
Citations per year

Countries citing papers authored by Samir N. Khleif

Since Specialization
Citations

This map shows the geographic impact of Samir N. Khleif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir N. Khleif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir N. Khleif more than expected).

Fields of papers citing papers by Samir N. Khleif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir N. Khleif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir N. Khleif. The network helps show where Samir N. Khleif may publish in the future.

Co-authorship network of co-authors of Samir N. Khleif

This figure shows the co-authorship network connecting the top 25 collaborators of Samir N. Khleif. A scholar is included among the top collaborators of Samir N. Khleif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir N. Khleif. Samir N. Khleif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 2
5 1
6 170
7 3
8
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Studybreakdown →
224
9 2
10 38
11 14
12 87
13 61
14 117
15 127
16 41
17 38
18 36
19 80
20 72

About Samir N. Khleif

Samir N. Khleif is a scholar working on Immunology, Biological Psychiatry and Oncology, having authored 114 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (54 papers), Cancer Immunotherapy and Biomarkers (53 papers) and CAR-T cell therapy research (21 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (1.9k citations) and Biological Psychiatry (70 citations). Samir N. Khleif has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Gregory A. Otterson, Mikayel Mkrtichyan, Frederic J. Kaye, Rasha Abu Eid, Jay A. Berzofsky, Amy Coxon, Scott Antonia, Seema Gupta, Neil H. Segal and Joseph R. Nevins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026